Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company headquartered in Wayne, Pennsylvania, has captured investor attention with an impressive potential upside of 137.39%, according to recent analyst ratings. Specializing in..
Nyxoah SA (NYSE: NYXH), a promising player in the healthcare sector specializing in medical instruments and supplies, has caught the attention of investors with its innovative solutions to treat obstructive..
NetClass Technology Inc (NTCL) is a Singapore-based company operating in the technology sector, specifically within the software application industry. As a relatively new player in the market, having been incorporated..
Heron Therapeutics, Inc. (NASDAQ: HRTX), a biotechnology company at the forefront of innovative therapeutic solutions, is catching the eye of investors with a staggering potential upside of 284.62%. Based in..
Agora, Inc. (NASDAQ: API), a prominent player in the technology sector, continues to capture investor interest with its innovative real-time engagement platform. Specializing in software applications, Agora stands at the..
Shopify Inc. (NYSE: SHOP), a leader in the technology sector, continues to captivate the investment community with its robust growth trajectory and compelling market presence. Despite the recent dip in..
UroGen Pharma Ltd. (NASDAQ: URGN), a biotechnology company specializing in urothelial and specialty cancers, presents a fascinating opportunity for investors looking to capitalize on its innovative treatment pipeline and robust..
Full Truck Alliance Co. Ltd. (NYSE: YMM), a pivotal player in the technology sector, operates a digital freight platform that connects shippers with truckers across China and Hong Kong. With..
Investors with an eye on the biotechnology sector might find Cartesian Therapeutics, Inc. (RNAC) a compelling candidate, especially given its remarkable potential upside of 455.80%. As a clinical-stage biotechnology company,..
Mereo BioPharma Group plc (NASDAQ: MREO) is a London-based biopharmaceutical company making waves in the biotechnology sector. With a market capitalization of $62.87 million, Mereo BioPharma is focused on the..
Anbio Biotechnology (NNNN), a promising player in the healthcare sector, operates within the medical instruments and supplies industry. Headquartered in Frankfurt am Main, Germany, this biotech company has carved out..
Cidara Therapeutics, Inc. (NASDAQ: CDTX) stands out in the biotechnology landscape with a focus on developing targeted therapies for life-threatening diseases. Despite a robust market cap of $6.96 billion, the..
ZoomInfo Technologies Inc. (NASDAQ: GTM) stands as a dynamic player within the technology sector, specifically in the software application industry. With a focus on providing go-to-market intelligence and engagement platforms,..
DocuSign, Inc. (NASDAQ: DOCU), a leader in electronic signature solutions, continues to capture attention in the technology sector with its innovative products and substantial potential upside. The company’s current stock..
TotalEnergies SE (TTE), a French energy giant with a market cap of $166.48 billion, is making waves in the oil and gas integrated industry. As a multi-energy company, TotalEnergies produces..
Gossamer Bio, Inc. (NASDAQ: GOSS), a San Diego-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at addressing pulmonary arterial hypertension (PAH). With..
AMTD Digital Inc. (HKD), a relatively new player in the technology sector, has been capturing attention with its astounding revenue growth of 1,085.90%. Despite this impressive figure, investors might find..
Immutep Limited (NASDAQ: IMMP), an innovative player in the biotechnology sector, is capturing the attention of investors with its ambitious focus on developing immunotherapies for cancer and autoimmune diseases. The..
Investors eyeing the healthcare sector might find Senseonics Holdings, Inc. (NYSE: SENS) an intriguing prospect, particularly with its impressive projected upside of 145.67%. Specializing in continuous glucose monitoring (CGM) systems,..
Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is making significant strides in the precision oncology sector, focusing on therapies for RAS/MAPK pathway-driven cancers. With a market capitalization of $3.58..
